???!





[link to longnow.org (secure)]



[link to www.chiefhealthcareexecutive.com (secure)]


[link to en.wikipedia.org (secure)]









“President Biden has sketched out a vision for a new research agency that undertakes cutting-edge research that could offer high risks and high rewards.

Now, Biden has made his choice to lead the new agency, the Advanced Research Projects Agency for Health (ARPA-H).

The president selected Renee Wegrzyn to be the agency’s first director. He announced his plan to appoint her on Sept. 12, the 60th anniversary of President John F. Kennedy’s famous moonshot speech, just as Biden pushed to reinvigorate his own “Cancer Moonshot”



“Wegrzyn has worked at two agencies that have inspired Biden’s new research agency: The Defense Advanced Research Projects Agency and the Intelligence Advanced Research Projects Agency.

At DARPA, Wegrzyn used synthetic biology and gene editing to improve biosecurity and support public health efforts. Since joining Gingko in 2020, Wegrzyn has helped develop the company’s pipeline for biosecurity and develop new tools to attack infectious diseases, the firm said in a news release.“

“Renee Diane Wegrzyn (born 1976/1977)[1] is an American applied biologist who has served as the inaugural director of the Advanced Research Projects Agency for Health since October 2022.“


….who the heck ends up being born “1976/1977” ??

??!


[link to attend.ieee.org (secure)]





“Dr. Renee Wegrzyn is a Program Manager in the Biological Technologies Office (BTO) of the Defense Advanced Research Projects Agency (DARPA), where she is pioneering disruptive approaches to leverage the tools of synthetic biology and gene editing to enhance biosecurity, support the domestic bioeconomy, and outpace infectious disease. She actively manages a portfolio at DARPA that includes the Living Foundries:1000 Molecules program, which seeks to transform biology into an engineering practice by developing the tools, technologies, methodologies, and infrastructure to prototype and scale engineered microbes that can produce molecules that are of value for government and commercial use; Safe Genes, which aims to deliver novel biological capabilities to facilitate the safe and expedient pursuit of advanced genome editing applications, while mitigating the risk of unintentional consequences or intentional misuse of these technologies; and Preemptive Expression of Protective Alleles and Response Elements (PREPARE), which aims to develop a new class of generalizable medical countermeasures that safely and temporarily tunes the activity of innate protective genes.“